MA50815A - Dépôt polymère à changement de charge pour l'administration d'insuline déclenchée par le glucose avec une réponse ultra-rapide - Google Patents

Dépôt polymère à changement de charge pour l'administration d'insuline déclenchée par le glucose avec une réponse ultra-rapide

Info

Publication number
MA50815A
MA50815A MA050815A MA50815A MA50815A MA 50815 A MA50815 A MA 50815A MA 050815 A MA050815 A MA 050815A MA 50815 A MA50815 A MA 50815A MA 50815 A MA50815 A MA 50815A
Authority
MA
Morocco
Prior art keywords
glucose
ultra
delivery
load change
rapid response
Prior art date
Application number
MA050815A
Other languages
English (en)
Inventor
Zhen Gu
Jinqiang Wang
Original Assignee
Univ North Carolina State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina State filed Critical Univ North Carolina State
Publication of MA50815A publication Critical patent/MA50815A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MA050815A 2017-11-21 2018-11-20 Dépôt polymère à changement de charge pour l'administration d'insuline déclenchée par le glucose avec une réponse ultra-rapide MA50815A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762589091P 2017-11-21 2017-11-21

Publications (1)

Publication Number Publication Date
MA50815A true MA50815A (fr) 2020-09-30

Family

ID=66632129

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050815A MA50815A (fr) 2017-11-21 2018-11-20 Dépôt polymère à changement de charge pour l'administration d'insuline déclenchée par le glucose avec une réponse ultra-rapide

Country Status (6)

Country Link
US (1) US11813352B2 (fr)
EP (1) EP3713594A4 (fr)
JP (1) JP7479287B2 (fr)
CN (1) CN111629746B (fr)
MA (1) MA50815A (fr)
WO (1) WO2019104006A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11850285B2 (en) 2017-03-07 2023-12-26 North Carolina State University Insulin-responsive glucagon delivery patch
WO2019104006A1 (fr) 2017-11-21 2019-05-31 North Carolina State University Dépôt polymère à changement de charge pour l'administration d'insuline déclenchée par le glucose avec une réponse ultra-rapide
CN112842333A (zh) * 2020-12-31 2021-05-28 华中科技大学 一种可视化葡萄糖浓度检测微针贴片、制备方法及应用
CN113197838B (zh) * 2021-03-31 2022-08-23 浙江大学 一种无酶糖敏微针贴及其温和制备方法
WO2024026280A1 (fr) * 2022-07-26 2024-02-01 University Of Notre Dame Du Lac Réseaux de micro-aiguilles polymères réticulés par des complexes de pba-diol pour l'administration d'insuline sensible au glucose

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137697B1 (en) * 2004-10-05 2012-03-20 Gp Medical, Inc. Nanoparticles for protein/peptide delivery and delivery means thereof
CN101273961A (zh) * 2007-03-30 2008-10-01 中国人民解放军总医院 葡萄糖敏感水凝胶
US9101547B2 (en) 2011-08-04 2015-08-11 Nano And Advanced Materials Institute Limited Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery
WO2014179344A1 (fr) 2013-04-30 2014-11-06 Massachusetts Institute Of Technology Gels à nanoréseau injectables pour le traitement du diabète
CN107530296B (zh) * 2015-04-21 2021-06-22 北卡罗来纳州立大学 使用缺氧敏感性纳米复合材料的葡萄糖响应性胰岛素递送系统
CN104811694B (zh) * 2015-04-28 2017-03-08 华为技术有限公司 一种视频数据质量评估的方法和装置
JP6784352B2 (ja) * 2015-05-11 2020-11-11 国立大学法人 東京医科歯科大学 インスリン送達用デバイス
WO2017069282A1 (fr) * 2015-10-23 2017-04-27 国立大学法人東京医科歯科大学 Dispositif d'administration de médicament
WO2019104006A1 (fr) 2017-11-21 2019-05-31 North Carolina State University Dépôt polymère à changement de charge pour l'administration d'insuline déclenchée par le glucose avec une réponse ultra-rapide

Also Published As

Publication number Publication date
WO2019104006A1 (fr) 2019-05-31
JP2021504448A (ja) 2021-02-15
CN111629746A (zh) 2020-09-04
CN111629746B (zh) 2024-04-16
JP7479287B2 (ja) 2024-05-08
US11813352B2 (en) 2023-11-14
EP3713594A4 (fr) 2021-11-03
EP3713594A1 (fr) 2020-09-30
US20200360269A1 (en) 2020-11-19

Similar Documents

Publication Publication Date Title
MA50815A (fr) Dépôt polymère à changement de charge pour l'administration d'insuline déclenchée par le glucose avec une réponse ultra-rapide
MA50557A (fr) Pistons pour dispositifs d'administration de médicament
MA54623A (fr) Système d'administration d'insuline répondant au glucose utilisant des nanocomposites sensibles à l'hypoxie
MA49949A (fr) Mécanisme d'insertion d'aiguille pour dispositif d'administration de médicament
MA50904A (fr) Mécanisme d'insertion d'aiguille pour dispositif d'administration de médicament
MA51617A (fr) Mécanisme d'administration de médicament
MX2016001018A (es) Composiciones estabilizadas de anticuerpos.
NZ732213A (en) Lanthionine synthetase c-like 2-based therapeutics
FR3032421B1 (fr) Ensemble pour aeronef comprenant une structure primaire de mat d'accrochage integree a la structure de l'element de voilure
FR3003171B1 (fr) Nouveaux medicaments comprenant une composition d'anticorps enrichie en isoforme de charge majoritaire
PL3337532T3 (pl) Zestaw do wlewu dożylnego
DK3256133T3 (da) Intravenøs infusionsdoseringsform
MA42458A (fr) Systèmes améliorés d'administration de nanoparticules
MA49393A (fr) Poly(phosphoesters) destinés à l'administration d'acides nucléiques
IL272876B (en) Repeated administration of large doses of [6r]-mthf in 5-fluorouracil chemotherapy
FR3042309B1 (fr) Structure dbc amelioree dotee d'un support integrant un materiau a changement de phase
MA41866A (fr) Molécules à auto-assemblage pour l'administration ciblée de médicaments
EP3721920A4 (fr) Injecteur de médicament liquide comprenant un compteur de bolus
FR3038840B1 (fr) Dispositif de securite pour une seringue d'injection.
FR3032658B1 (fr) Dispositif d'articulation pour le reglage de l'inclinaison d'un dossier de siege
Wilson Coming in to Indigenous Sovereignty
GB201612274D0 (en) Poloxamer-based intralesional injections for the delivery of chemotherapeutic agents
Mukmin et al. TA’LÎM MAHÂRAH AL-QIRÂ’AH LIKULLI MARÂHIL AL-TA’LÎM
Kwon et al. A study on the strategy for innovation platform management to promote venture ecosystem
Dixon Field Journal of JR Dixon (JRD Specimens 30722-30957)